B3023

Bumetanide

≥98% (TLC), powder, Na⁺/K⁺/Cl⁻ cotransporter inhibitor

• Sinónimos: 3-(Aminosulfonyl)-5-(butylamino)-4-phenoxybenzoic acid
• Fórmula empírica (notación de Hill): C₁₇H₂₀N₂O₅S
• Número CAS: 28395-03-1
• Peso molecular: 364.42
• NACRES: NA.77
• PubChem Substance ID: 24278265
• UNSPSC Code: 12352200
• EC Number: 249-004-6
• MDL number: MFCD00078949
• Assay: ≥98%
• Form: powder

Propiedades

• Nombre del producto: Bumetanide, ≥98%
• Quality Segment: 100
• assay: ≥98%
• form: powder
• originator: Roche
• SMILES string: CCCCNc1cc(cc(c1Oc2ccccc2)S(N)(=O)=O)C(O)=O
• InChI: 1S/C17H20N2O5S/c1-2-3-9-19-14-10-12(17(20)21)11-15(25(18,22)23)16(14)24-13-7-5-4-6-8-13/h4-8,10-11,19H,2-3,9H2,1H3,(H,20,21)(H2,18,22,23)
• InChI key: MAEIEVLCKWDQJH-UHFFFAOYSA-N
• Gene Information: human ... SLC12A1(6557)

Descripción

Biochem/physiol Actions

Inhibitor of Na⁺/K⁺/Cl^- cotransporter.

Features and Benefits

This compound is a featured product for ADME Tox research. Click here to discover more featured ADME Tox products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm.

This compound was developed by Roche. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Información de seguridad

• Clase de almacenamiento: 11 - Combustible Solids
• ¿Qué está pasando?: WGK 3
• Punto de inflamación (°F): Not applicable
• Punto de inflamación (°C): Not applicable
• EPI (equipos de protección individual): Eyeshields, Gloves, type N95 (US)